Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tropism of mesenchymal stem cell toward CD133+ stem cell of glioblastoma in vitro and promote tumor proliferation in vivo.
Pavon LF, Sibov TT, de Souza AV, da Cruz EF, Malheiros SMF, Cabral FR, de Souza JG, Boufleur P, de Oliveira DM, de Toledo SRC, Marti LC, Malheiros JM, Paiva FF, Tannús A, de Oliveira SM, Chudzinski-Tavassi AM, de Paiva Neto MA, Cavalheiro S. Pavon LF, et al. Stem Cell Res Ther. 2018 Nov 9;9(1):310. doi: 10.1186/s13287-018-1049-0. Stem Cell Res Ther. 2018. PMID: 30413179 Free PMC article.
Mesenchymal stem cell-like properties of CD133+ glioblastoma initiating cells.
Pavon LF, Sibov TT, de Oliveira DM, Marti LC, Cabral FR, de Souza JG, Boufleur P, Malheiros SM, de Paiva Neto MA, da Cruz EF, Chudzinski-Tavassi AM, Cavalheiro S. Pavon LF, et al. Oncotarget. 2016 Jun 28;7(26):40546-40557. doi: 10.18632/oncotarget.9658. Oncotarget. 2016. PMID: 27244897 Free PMC article.
Establishment of primary cell culture and an intracranial xenograft model of pediatric ependymoma: a prospect for therapy development and understanding of tumor biology.
Pavon LF, Sibov TT, Caminada de Toledo SR, Mara de Oliveira D, Cabral FR, Gabriel de Souza J, Boufleur P, Marti LC, Malheiros JM, Ferreira da Cruz E, Paiva FF, Malheiros SMF, de Paiva Neto MA, Tannús A, Mascarenhas de Oliveira S, Silva NS, Cappellano AM, Petrilli AS, Chudzinski-Tavassi AM, Cavalheiro S. Pavon LF, et al. Oncotarget. 2018 Apr 24;9(31):21731-21743. doi: 10.18632/oncotarget.24932. eCollection 2018 Apr 24. Oncotarget. 2018. PMID: 29774098 Free PMC article.
New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X.
Pavon LF, Capper D, Sibov TT, de Toledo SRC, Thomale UW, de Souza JG, Cabral FR, Berra CM, Silva da Costa MD, Mendonça Niçacio J, Dastoli PA, de Oliveira DM, Malheiros SMF, da Cruz EF, Malheiros JM, de Oliveira SM, Silva NS, Petrilli AS, Cappellano AM, Brunialti MC, Salomão R, de Paiva Neto MA, Chudzinski-Tavassi AM, Cavalheiro S. Pavon LF, et al. Sci Rep. 2019 Jul 10;9(1):9973. doi: 10.1038/s41598-019-45799-4. Sci Rep. 2019. PMID: 31292491 Free PMC article.
Modulation of stress and immune response by Amblyomin-X results in tumor cell death in a horse melanoma model.
Lichtenstein F, Iqbal A, de Lima Will SEA, Bosch RV, DeOcesano-Pereira C, Goldfeder MB, Chammas R, Trufen CEM, Morais KLP, de Souza JG, Natalino RJM, de Azevedo IJ, Nishiyama Junior MY, Oliveira U, Alves FIA, Araujo JM, Lobba ARM, Chudzinski-Tavassi AM. Lichtenstein F, et al. Sci Rep. 2020 Apr 14;10(1):6388. doi: 10.1038/s41598-020-63275-2. Sci Rep. 2020. PMID: 32286411 Free PMC article.
103 results